JP2017181387A - 医薬組成物の形成する膜の評価方法 - Google Patents

医薬組成物の形成する膜の評価方法 Download PDF

Info

Publication number
JP2017181387A
JP2017181387A JP2016071463A JP2016071463A JP2017181387A JP 2017181387 A JP2017181387 A JP 2017181387A JP 2016071463 A JP2016071463 A JP 2016071463A JP 2016071463 A JP2016071463 A JP 2016071463A JP 2017181387 A JP2017181387 A JP 2017181387A
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
film
evaluation method
water
evaluating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016071463A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017181387A5 (enExample
Inventor
孝明 増田
Takaaki Masuda
孝明 増田
香穂梨 藤井
Kahori Fujii
香穂梨 藤井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pola Pharma Inc
Nihon Nohyaku Co Ltd
Original Assignee
Pola Pharma Inc
Nihon Nohyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Pharma Inc, Nihon Nohyaku Co Ltd filed Critical Pola Pharma Inc
Priority to JP2016071463A priority Critical patent/JP2017181387A/ja
Publication of JP2017181387A publication Critical patent/JP2017181387A/ja
Publication of JP2017181387A5 publication Critical patent/JP2017181387A5/ja
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
JP2016071463A 2016-03-31 2016-03-31 医薬組成物の形成する膜の評価方法 Pending JP2017181387A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2016071463A JP2017181387A (ja) 2016-03-31 2016-03-31 医薬組成物の形成する膜の評価方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2016071463A JP2017181387A (ja) 2016-03-31 2016-03-31 医薬組成物の形成する膜の評価方法

Publications (2)

Publication Number Publication Date
JP2017181387A true JP2017181387A (ja) 2017-10-05
JP2017181387A5 JP2017181387A5 (enExample) 2019-04-04

Family

ID=60005971

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016071463A Pending JP2017181387A (ja) 2016-03-31 2016-03-31 医薬組成物の形成する膜の評価方法

Country Status (1)

Country Link
JP (1) JP2017181387A (enExample)

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1201386A (zh) * 1995-09-12 1998-12-09 阿斯特拉公司 用作活性化合物给药载体的微乳剂
JP2000290153A (ja) * 1999-04-09 2000-10-17 Kao Corp 皮膚外用剤
US20070082870A1 (en) * 2005-10-11 2007-04-12 Buchanan Charles M Pharmaceutical formulations of cyclodextrins and antifungal azole compounds
WO2007102243A1 (ja) * 2006-03-08 2007-09-13 Nihon Nohyaku Co., Ltd. 外用の医薬組成物
WO2007102241A1 (ja) * 2006-03-08 2007-09-13 Nihon Nohyaku Co., Ltd. 外用の医薬組成物
WO2009031643A1 (ja) * 2007-09-05 2009-03-12 Pola Pharma Inc. 抗真菌組成物
JP2012214409A (ja) * 2011-03-31 2012-11-08 Ivy Cosmetics Corp Ｗ／ｏ／ｗ型複合エマルション
JP2013223715A (ja) * 2012-03-19 2013-10-31 Pola Pharma Inc 抗真菌医薬組成物が充填された樹脂容器
WO2017170509A1 (ja) * 2016-03-31 2017-10-05 株式会社ポーラファルマ 非晶質化剤、非晶質化剤を含んでなる非晶質の組成物及びその使用

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1201386A (zh) * 1995-09-12 1998-12-09 阿斯特拉公司 用作活性化合物给药载体的微乳剂
JP2000290153A (ja) * 1999-04-09 2000-10-17 Kao Corp 皮膚外用剤
US20070082870A1 (en) * 2005-10-11 2007-04-12 Buchanan Charles M Pharmaceutical formulations of cyclodextrins and antifungal azole compounds
WO2007102243A1 (ja) * 2006-03-08 2007-09-13 Nihon Nohyaku Co., Ltd. 外用の医薬組成物
WO2007102241A1 (ja) * 2006-03-08 2007-09-13 Nihon Nohyaku Co., Ltd. 外用の医薬組成物
WO2009031643A1 (ja) * 2007-09-05 2009-03-12 Pola Pharma Inc. 抗真菌組成物
JP2012214409A (ja) * 2011-03-31 2012-11-08 Ivy Cosmetics Corp Ｗ／ｏ／ｗ型複合エマルション
JP2013223715A (ja) * 2012-03-19 2013-10-31 Pola Pharma Inc 抗真菌医薬組成物が充填された樹脂容器
WO2017170509A1 (ja) * 2016-03-31 2017-10-05 株式会社ポーラファルマ 非晶質化剤、非晶質化剤を含んでなる非晶質の組成物及びその使用
JP2017186317A (ja) * 2016-03-31 2017-10-12 株式会社ポーラファルマ 非晶質化剤、非晶質化剤を含んでなる非晶質の組成物及びその使用

Similar Documents

Publication Publication Date Title
US12150955B2 (en) Iodine compositions
TWI692364B (zh) 含有迪夸弗索之點眼液
JP5529539B2 (ja) 医薬組成物
JP7094321B2 (ja) 少なくとも１種のセラミド、少なくとも１種のスフィンゴイド塩基及びクエン酸トリエチルを含有する組成物
TW201701881A (zh) 水性點眼液
DE60117248T2 (de) Parenterale lösung, welche amiodaron enthält
JP2004517829A (ja) 皮膚科用処方剤
JP2017181387A (ja) 医薬組成物の形成する膜の評価方法
JP2015227354A (ja) モメタゾンとプロピレングリコールとの水中油型エマルジョン
DE112011104683B4 (de) Nichtionische N-Vinylbutyrolactam-lod-Lösung mit hoher Stabilität und deren Herstellungsverfahren
AU2017244688B2 (en) Amorphizing agent, Amorphous composition comprising Amorphizing agent and utilization thereof
WO2004073713A1 (ja) ピルフェニドンのゲル剤
US20240180827A1 (en) Suspension containing heterocyclidene acetamide derivative
WO2017094204A1 (en) Luliconazole as anti-acanthamoeba agent and method for producing the same
Xu et al. A new polymorph of glipizide with enhanced properties obtained using environmentally friendly methods
JP3805203B2 (ja) 点眼用水性懸濁製剤およびその製造方法
CN102920716B (zh) 复方抗球虫药物磺胺氯吡嗪钠溶液的制备方法
EP3727299B1 (en) Oral care compositions comprising an ethoxylated amine of a fatty acid
WO2004073680A1 (ja) 液滴分散型軟膏剤
JPH0314813B2 (enExample)
WO2017208847A1 (ja) 医薬組成物
JP2025181422A (ja) 乳化製剤
CN116942604A (zh) 一种丁苯酞注射液及其制备方法
CA3220425A1 (en) Pharmaceutical composition, and aprepitant injection and freeze-dried powder injection
EA048172B1 (ru) Антибактериальный препарат

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190220

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190220

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20200122

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200303

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20200501

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20201006